Fig 1.
(A) Distribution of very late antigen-4 (VLA-4) expression among the 216 patients in our study cohort. (B) Distribution of patients with FLT3 internal tandem duplication (ITD) across quartiles of VLA-4 expression. (C) Mean VLA-4 expression in patients with low-risk, standard-risk, and high-risk disease. MFI, mean fluorescence intensity.